查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1943272

化學資訊學市場－全球產業規模、佔有率、趨勢、機會及預測（按應用、最終用戶、地區和競爭格局分類，2021-2031年）

Cheminformatics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球化學資訊學市場預計將從 2025 年的 43.6 億美元成長到 2031 年的 86.4 億美元，複合年成長率達到 12.07%。

該領域利用計算策略來組織和解讀化學數據，從而輔助分子資訊的儲存、搜尋和建模。市場成長趨勢的驅動力在於對精簡藥物發現流程日益成長的需求，以及處理高通量篩檢產生的大量資料集的需求。這一發展勢頭也得到了業界的大力支持。例如，歐洲製藥工業協會聯合會（EFPIA）估計，到2023年，歐洲以研發為基礎的製藥業將在研發方面投入500億歐元。如此龐大的投入凸顯了數位化解決方案在提高研發效率和縮短開發週期方面的重要作用。

市場概覽
預測期 2027-2031
市場規模：2025年 43.6億美元
市場規模：2031年 86.4億美元
複合年成長率：2026-2031年 12.07%
成長最快的細分市場 化學分析
最大的市場 北美洲

然而，市場成長的一大障礙是缺乏兼具化學和資訊科技專業知識的人才。這種專業技能的匱乏阻礙了先進資訊基礎設施的成功實施。此外，該行業還面臨不同平台間數據標準化不一致的問題，這妨礙了協作研究所需的無縫整合。這些互通性挑戰有可能減緩該領域先進技術的採用和應用。

市場促進因素

人工智慧和機器學習在藥物研發領域的快速應用，大大推動了化學資訊學產業的發展。這些技術使科學家能夠預測分子相互作用並最佳化先導化合物，從而催生了對能夠管理複雜數據的高級軟體框架的需求。這種技術融合在小分子藥物設計領域尤其重要，因為演算法需要分析龐大的化合物庫。禮來公司於2024年1月宣布與Isomorphic Labs建立策略夥伴關係就是一個很好的例子。該合作包括4500萬美元的預付款，用於推動人工智慧主導的藥物設計。此類合作凸顯了將計算預測與實驗室檢驗相結合的資訊平台的重要性。

此外，製藥公司不斷增加的研發投入是推動市場發展的主要動力。為了維持開發平臺的競爭力，各公司正大力投資數位轉型工具，以最佳化研發生命週期。這些資金用於購置關鍵的篩檢和建模軟體。根據默克公司2024年2月發布的報告顯示，該公司2023會計年度的研發支出飆升至305億美元。嚴格的數據完整性監管要求進一步強化了這一趨勢。美國食品藥物管理局（FDA）在2023年核准了55種新分子實體，如此大規模的核准需要強大的資訊系統來處理與監管申報相關的嚴苛資料管理。

市場挑戰

全球化學資訊學市場面臨的一大障礙是同時精通化學和資訊科技的專業人才短缺。隨著生技和製藥公司越來越依賴運算技術來建立化合物資料模型，能夠理解基礎科學知識和複雜資料結構的人才需求遠遠超過供給。這種人才短缺阻礙了資訊系統的順利應用，迫使企業推遲關鍵數位化解決方案的實施。如果缺乏能夠跨越不同學科的人才，企業在最佳化大規模化學資料管理方面將面臨挑戰，這可能會阻礙關鍵的研發活動。

近期行業統計數據證實，技能缺口正在擴大，並造成營運瓶頸。根據皮斯托亞聯盟（Pistoia Alliance）的數據顯示，34%的生命科學實驗室認為缺乏熟練人才是採用先進數位技術的主要障礙，高於前一年的23%。技術技能的日益短缺直接限制了市場的持續成長能力。如果企業無法獲得管理這些平台所需的人才，化學資訊學帶來的效率提升將無法實現，導致研發週期延長，市場成長受限。

市場趨勢

向雲端原生和SaaS部署模式的轉變正在改變全球化學資訊學市場，以擴充性的數位平台取代固定的本地硬體。這種轉變使製藥公司能夠分散其研究活動，並促進地理位置分散的團隊之間的順暢協作。利用雲端基礎設施，企業可以有效應對化學數據的快速成長，而無需承擔傳統硬體相關的巨額資本成本。隨著主要產業參與者將其數位化營運遷移到雲端框架，這種策略轉變顯而易見。例如，Veeva Systems於2025年6月宣布擴大與AWS的合作，以支援超過50個生命科學應用程式，凸顯了該產業對雲端原生環境以實現營運柔軟性的依賴。

同時，隨著業界重心從小分子藥物轉向複雜的治療性蛋白質，專為生物製藥和大分子設計的專用工具的重要性日益凸顯。這一趨勢推動了創新資訊科學解決方案的開發，這些解決方案旨在管理生物製藥傳統系統無法充分處理這些數據。隨著研發開發平臺日益側重於大分子治療藥物，對用於建模和模擬這些實體的專用軟體的需求也隨之激增。生物製藥主導產業的強勁財務預測進一步推動了這個市場發展。 2025年6月，IQVIA人類資料科學研究所發布報告稱，到2029年，全球腫瘤治療支出將達到4,410億美元，凸顯了先進資訊科學技術對於支持這一蓬勃發展領域的迫切需求。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球化學資訊學市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按應用領域（化學分析、藥物發現/檢驗、虛擬篩檢等）
    • 依最終用戶（化學/製藥公司、學術/研究機構、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美化學資訊學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章 歐洲化學資訊學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區化學資訊學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲化學資訊學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章 南美洲化學資訊學市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球化學資訊學市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • PerkinElmer NC.
  • Accelrys Software Inc.
  • Chemical Computing Group, Inc.
  • Certara, LP
  • Advanced Chemistry Development, Inc.
  • BioSolveIT GmbH
  • Dassault Systemes
  • ChemAxon Inc.
  • Eurofins Panlabs Inc.
  • Jubilant Biosys Inc.
  • Molecular Discovery Ltd.
  • OpenEye Scientific Software Inc.
  • SchrOdinger Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 12904

The Global Cheminformatics Market is projected to expand from USD 4.36 Billion in 2025 to USD 8.64 Billion by 2031, achieving a compound annual growth rate of 12.07%. This field utilizes computational strategies to organize and interpret chemical data, supporting the storage, retrieval, and modeling of molecular information. The market's upward trajectory is driven by the growing necessity for streamlined drug discovery processes and the handling of massive datasets generated by high-throughput screening. This momentum is supported by substantial industry funding; for instance, the European Federation of Pharmaceutical Industries and Associations estimated that the research-based pharmaceutical sector invested €50,000 million in R&D across Europe in 2023. Such spending highlights the essential function of digital solutions in maximizing research productivity and shortening development cycles.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.36 Billion
Market Size 2031USD 8.64 Billion
CAGR 2026-203112.07%
Fastest Growing SegmentChemical Analysis
Largest MarketNorth America

Conversely, market growth faces a significant hurdle due to a shortage of workforce talent holding combined proficiency in chemistry and information technology. This lack of specialized skills hinders the successful deployment of sophisticated informatics infrastructures. Furthermore, the industry struggles with data standardization inconsistencies across various platforms, which impede the seamless integration needed for collaborative scientific efforts. These interoperability challenges threaten to retard the widespread acceptance and application of these advanced technologies within the sector.

Market Driver

The rapid incorporation of AI and machine learning into drug discovery acts as a major propellant for the cheminformatics industry. These technologies empower scientists to forecast molecular interactions and refine lead compounds, creating a need for sophisticated software frameworks capable of managing complex data. This technological convergence is particularly crucial for small molecule design, where algorithms analyze extensive chemical libraries. A case in point is Eli Lilly and Company's January 2024 announcement regarding a strategic partnership with Isomorphic Labs, which included a $45 million upfront commitment to advance AI-led drug design. Such alliances underscore the necessity of informatics platforms to connect computational forecasts with experimental validation in the lab.

Additionally, escalating R&D expenditures by pharmaceutical corporations serve as a primary catalyst for the market. Firms are directing significant funds toward digital transformation tools that optimize the research lifecycle to sustain competitive development pipelines. This financial backing enables the acquisition of essential screening and modeling software. As reported by Merck & Co., Inc. in February 2024, the company's full-year R&D expenses for 2023 surged to $30.5 billion. This trend is further strengthened by regulatory requirements for strict data integrity; the U.S. Food and Drug Administration approved 55 new molecular entities in 2023, a volume that necessitates powerful informatics systems to handle the rigorous data management associated with regulatory submissions.

Market Challenge

A critical obstacle facing the Global Cheminformatics Market is the shortage of professionals who possess dual competency in both chemistry and information technology. As biotechnology and pharmaceutical firms increasingly depend on computational techniques to model compound data, the requirement for staff capable of understanding scientific fundamentals alongside complex data structures has exceeded availability. This talent deficit creates barriers to the seamless implementation of informatics systems, compelling organizations to postpone the rollout of vital digital solutions. Without a workforce equipped to bridge these distinct fields, companies face difficulties in optimizing large-scale chemical data management, effectively halting key research and development endeavors.

Recent industry statistics confirm that this skills gap is widening, creating an operational bottleneck. According to the Pistoia Alliance, 34 percent of life science laboratories identified the lack of skilled personnel as a major impediment to adopting advanced digital technologies in 2025, a rise from 23 percent the prior year. This growing shortage of technical proficiency directly limits the market's capacity to maintain its expansion. If organizations fail to acquire the necessary human capital to manage these platforms, the anticipated efficiency improvements from cheminformatics remain out of reach, leading to prolonged development schedules and constrained market growth.

Market Trends

The shift toward Cloud-Native and SaaS deployment models is transforming the Global Cheminformatics Market by supplanting rigid on-premise hardware with scalable digital platforms. This migration enables pharmaceutical companies to decentralize their research activities, promoting fluid collaboration among dispersed teams. By utilizing cloud infrastructures, organizations can effectively handle the rapid expansion of chemical data without incurring the heavy capital costs linked to traditional hardware. This strategic pivot is highlighted by leading industry players moving their digital operations to cloud frameworks; for instance, Veeva Systems announced in June 2025 an extension of its collaboration with AWS to support over 50 life sciences applications, emphasizing the sector's dependence on cloud-native environments for operational flexibility.

Simultaneously, the rise of specialized tools designed for biologics and large molecules is becoming increasingly significant as the industry shifts focus from small-molecule drugs to complex therapeutic proteins. This trend drives the creation of innovative informatics solutions tailored to manage the intricate structural data of biologics, which older systems cannot sufficiently process. As R&D pipelines place greater emphasis on large-molecule therapies, there is a surging need for specific software to model and simulate these entities. This market progression is bolstered by strong financial forecasts for biologics-dominated sectors; the IQVIA Institute for Human Data Science reported in June 2025 that global spending on oncology is expected to reach $441 billion by 2029, underlining the urgent requirement for advanced informatics to sustain this growing field.

Key Market Players

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • PerkinElmer NC.
  • Accelrys Software Inc.
  • Chemical Computing Group, Inc.
  • Certara, L.P.
  • Advanced Chemistry Development, Inc.
  • BioSolveIT GmbH
  • Dassault Systemes
  • ChemAxon Inc.
  • Eurofins Panlabs Inc.
  • Jubilant Biosys Inc.
  • Molecular Discovery Ltd.
  • OpenEye Scientific Software Inc.
  • SchrOdinger Inc.

Report Scope

In this report, the Global Cheminformatics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cheminformatics Market, By Application

  • Chemical Analysis
  • Drug Discovery and Validation
  • Virtual Screening
  • Others

Cheminformatics Market, By End User

  • Chemical & Pharmaceutical Companies
  • Academic & Research Institutions
  • Others

Cheminformatics Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cheminformatics Market.

Available Customizations:

Global Cheminformatics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cheminformatics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Chemical Analysis, Drug Discovery and Validation, Virtual Screening, Others)
    • 5.2.2. By End User (Chemical & Pharmaceutical Companies, Academic & Research Institutions, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Cheminformatics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cheminformatics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Cheminformatics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Cheminformatics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By End User

7. Europe Cheminformatics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cheminformatics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By End User
    • 7.3.2. France Cheminformatics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Cheminformatics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Cheminformatics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Cheminformatics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By End User

8. Asia Pacific Cheminformatics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Cheminformatics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By End User
    • 8.3.2. India Cheminformatics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Cheminformatics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Cheminformatics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Cheminformatics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By End User

9. Middle East & Africa Cheminformatics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Cheminformatics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE Cheminformatics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa Cheminformatics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By End User

10. South America Cheminformatics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Cheminformatics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia Cheminformatics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina Cheminformatics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Cheminformatics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Agilent Technologies Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Bio-Rad Laboratories Inc.
  • 15.3. PerkinElmer NC.
  • 15.4. Accelrys Software Inc.
  • 15.5. Chemical Computing Group, Inc.
  • 15.6. Certara, L.P.
  • 15.7. Advanced Chemistry Development, Inc.
  • 15.8. BioSolveIT GmbH
  • 15.9. Dassault Systemes
  • 15.10. ChemAxon Inc.
  • 15.11. Eurofins Panlabs Inc.
  • 15.12. Jubilant Biosys Inc.
  • 15.13. Molecular Discovery Ltd.
  • 15.14. OpenEye Scientific Software Inc.
  • 15.15. SchrOdinger Inc.

16. Strategic Recommendations

17. About Us & Disclaimer